Acorah Software Products - Accounts Production 16.0.110 false true 28 February 2023 1 March 2022 false 1 March 2023 28 February 2024 28 February 2024 07533058 Ms Panagiota Theodorou iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 07533058 2023-02-28 07533058 2024-02-28 07533058 2023-03-01 2024-02-28 07533058 frs-core:CurrentFinancialInstruments 2024-02-28 07533058 frs-core:Non-currentFinancialInstruments 2024-02-28 07533058 frs-core:ComputerEquipment 2024-02-28 07533058 frs-core:ComputerEquipment 2023-03-01 2024-02-28 07533058 frs-core:ComputerEquipment 2023-02-28 07533058 frs-core:FurnitureFittings 2024-02-28 07533058 frs-core:FurnitureFittings 2023-03-01 2024-02-28 07533058 frs-core:FurnitureFittings 2023-02-28 07533058 frs-core:ShareCapital 2024-02-28 07533058 frs-core:RetainedEarningsAccumulatedLosses 2024-02-28 07533058 frs-bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-28 07533058 frs-bus:FilletedAccounts 2023-03-01 2024-02-28 07533058 frs-bus:SmallEntities 2023-03-01 2024-02-28 07533058 frs-bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-28 07533058 frs-bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-28 07533058 frs-bus:Director1 2023-03-01 2024-02-28 07533058 frs-countries:EnglandWales 2023-03-01 2024-02-28 07533058 2022-02-28 07533058 2023-02-28 07533058 2022-03-01 2023-02-28 07533058 frs-core:CurrentFinancialInstruments 2023-02-28 07533058 frs-core:Non-currentFinancialInstruments 2023-02-28 07533058 frs-core:ShareCapital 2023-02-28 07533058 frs-core:RetainedEarningsAccumulatedLosses 2023-02-28
Registered number: 07533058
Integra Medical Reporting Limited
Unaudited Financial Statements
For The Year Ended 28 February 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 07533058
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 2,777 3,704
2,777 3,704
CURRENT ASSETS
Debtors 5 2,753 2,712
Cash at bank and in hand 62,680 55,435
65,433 58,147
Creditors: Amounts Falling Due Within One Year 6 (52,017 ) (33,749 )
NET CURRENT ASSETS (LIABILITIES) 13,416 24,398
TOTAL ASSETS LESS CURRENT LIABILITIES 16,193 28,102
Creditors: Amounts Falling Due After More Than One Year 7 (11,476 ) (21,226 )
PROVISIONS FOR LIABILITIES
Deferred Taxation (694 ) (926 )
NET ASSETS 4,023 5,950
CAPITAL AND RESERVES
Called up share capital 8 100 100
Profit and Loss Account 3,923 5,850
SHAREHOLDERS' FUNDS 4,023 5,950
Page 1
Page 2
For the year ending 28 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Ms Panagiota Theodorou
Director
18/11/2024
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Integra Medical Reporting Limited is a private company, limited by shares, incorporated in England & Wales, registered number 07533058 . The registered office is 47-49 Park Royal Road, Premier Business Centre, Park Royal, NW10 7LQ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover represents net invoiced sales of services, excluding value added tax.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Fixtures & Fittings 25%
Computer Equipment 25%
2.4. Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current or deferred taxation assets and liabilities are not discounted.
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted orsubstantively enacted by the balance sheet date.
Deferred tax 
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements.  Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
2.5. Revenue recognition
The revenue is recognised when the occurrence of a critical event arises in accordance with the Section 23 of Financial Reporting Standard 102.The revenue is recognised when the occurrence of a critical event arises in accordance with the Section 23 of Financial Reporting Standard 102.
2.6. Going Concern
As with most businesses the Company has been affected by the ongoing impact of exit from the European Union and the high level of interest in the UK economy. These have had an impact on the operations, customers, suppliers and staff. The Company is taking all the steps it can to protect the future of the business.
Although the total impact is still uncertain the director believes that it is appropriate to prepare the accounts on a going concern basis.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 4)
2 4
Page 3
Page 4
4. Tangible Assets
Fixtures & Fittings Computer Equipment Total
£ £ £
Cost
As at 1 March 2023 4,673 14,482 19,155
As at 28 February 2024 4,673 14,482 19,155
Depreciation
As at 1 March 2023 4,586 10,865 15,451
Provided during the period 22 905 927
As at 28 February 2024 4,608 11,770 16,378
Net Book Value
As at 28 February 2024 65 2,712 2,777
As at 1 March 2023 87 3,617 3,704
5. Debtors
2024 2023
£ £
Due within one year
Other debtors 2,753 2,712
6. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Bank loans and overdrafts 11,274 11,274
Other creditors 25,424 8,566
Taxation and social security 15,319 13,909
52,017 33,749
7. Creditors: Amounts Falling Due After More Than One Year
2024 2023
£ £
Bank loans 11,476 21,226
8. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 100 100
9. Dividends
2024 2023
£ £
On equity shares:
Final dividend paid 40,000 10,000
Page 4
Page 5
10. Related Party Transactions
During the year, total dividends of £13,600 (2023 - £3,400) were paid to the director.
Page 5